Joel Beatty
Stock Analyst at Baird
(3.98)
# 490
Out of 4,829 analysts
194
Total ratings
37.42%
Success rate
14.27%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Outperform | $30 → $29 | $14.37 | +101.81% | 2 | May 8, 2025 | |
| PTCT PTC Therapeutics | Maintains: Outperform | $70 → $66 | $44.23 | +49.22% | 15 | May 7, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $167 → $155 | $97.78 | +58.52% | 4 | May 7, 2025 | |
| COGT Cogent Biosciences | Maintains: Neutral | $8 → $7 | $4.81 | +45.53% | 5 | May 7, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Outperform | $160 → $162 | $107.76 | +50.33% | 5 | May 6, 2025 | |
| ALKS Alkermes | Maintains: Outperform | $38 → $41 | $30.13 | +36.08% | 3 | May 2, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $13 → $10 | $2.12 | +371.70% | 2 | Mar 25, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Outperform | $27 → $16 | $6.15 | +160.16% | 2 | Mar 7, 2025 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $32 → $16 | $3.87 | +313.44% | 2 | Mar 7, 2025 | |
| ARGX argenx SE | Maintains: Neutral | $650 → $680 | $549.27 | +23.80% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $117 → $73 | $38.35 | +90.35% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $23.37 | +36.93% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $1.45 | +451.72% | 3 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $32.49 | +130.84% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $3 → $11 | $4.61 | +138.61% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $7 | $1.85 | +278.38% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $54 → $72 | $14.73 | +388.80% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $58.86 | +10.43% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $175 | $66.84 | +161.82% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $9 | $6.57 | +36.99% | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $112 → $127 | $97.17 | +30.70% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $58 | $19.61 | +195.77% | 1 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $72 | $35.11 | +105.07% | 4 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $20 | $0.46 | +4,258.25% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $28 | $17.44 | +60.55% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.18 | +281.36% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $9.50 | +163.16% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $9 | $0.34 | +2,586.57% | 2 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $10.70 | +161.68% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $6.97 | +129.56% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.68 | -25.60% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.41 | +3,020.57% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $13.03 | +345.13% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $17.42 | +37.77% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $10.98 | +63.93% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $2.66 | +125.56% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $31 | $1.13 | +2,643.36% | 3 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $5.09 | +450.64% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $251.15 | -30.32% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $3.95 | +254.43% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $36.27 | +197.77% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $32.30 | +141.52% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $9.83 | +917.29% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $10.38 | +1,056.07% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $3.37 | +13,253.12% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.80 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $5.98 | +151.05% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $120 | $0.74 | +16,116.22% | 2 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $5.76 | +229.86% | 3 | Nov 10, 2017 |
Denali Therapeutics
May 8, 2025
Maintains: Outperform
Price Target: $30 → $29
Current: $14.37
Upside: +101.81%
PTC Therapeutics
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $44.23
Upside: +49.22%
Jazz Pharmaceuticals
May 7, 2025
Maintains: Outperform
Price Target: $167 → $155
Current: $97.78
Upside: +58.52%
Cogent Biosciences
May 7, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $4.81
Upside: +45.53%
Axsome Therapeutics
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $107.76
Upside: +50.33%
Alkermes
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $30.13
Upside: +36.08%
Larimar Therapeutics
Mar 25, 2025
Maintains: Outperform
Price Target: $13 → $10
Current: $2.12
Upside: +371.70%
Mind Medicine (MindMed)
Mar 7, 2025
Maintains: Outperform
Price Target: $27 → $16
Current: $6.15
Upside: +160.16%
Contineum Therapeutics
Mar 7, 2025
Maintains: Outperform
Price Target: $32 → $16
Current: $3.87
Upside: +313.44%
argenx SE
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $680
Current: $549.27
Upside: +23.80%
Mar 3, 2025
Maintains: Outperform
Price Target: $117 → $73
Current: $38.35
Upside: +90.35%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $23.37
Upside: +36.93%
Dec 13, 2024
Maintains: Outperform
Price Target: $10 → $8
Current: $1.45
Upside: +451.72%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $32.49
Upside: +130.84%
Nov 18, 2024
Upgrades: Outperform
Price Target: $3 → $11
Current: $4.61
Upside: +138.61%
Nov 15, 2024
Maintains: Outperform
Price Target: $6 → $7
Current: $1.85
Upside: +278.38%
Nov 12, 2024
Maintains: Outperform
Price Target: $54 → $72
Current: $14.73
Upside: +388.80%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $58.86
Upside: +10.43%
Oct 21, 2024
Maintains: Outperform
Price Target: $240 → $175
Current: $66.84
Upside: +161.82%
Oct 9, 2024
Maintains: Neutral
Price Target: $13 → $9
Current: $6.57
Upside: +36.99%
Aug 2, 2024
Maintains: Outperform
Price Target: $112 → $127
Current: $97.17
Upside: +30.70%
Jul 26, 2024
Initiates: Outperform
Price Target: $58
Current: $19.61
Upside: +195.77%
May 31, 2024
Maintains: Outperform
Price Target: $68 → $72
Current: $35.11
Upside: +105.07%
May 15, 2024
Maintains: Outperform
Price Target: $45 → $20
Current: $0.46
Upside: +4,258.25%
May 9, 2024
Maintains: Outperform
Price Target: $31 → $28
Current: $17.44
Upside: +60.55%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.18
Upside: +281.36%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $9.50
Upside: +163.16%
Mar 19, 2024
Maintains: Outperform
Price Target: $11 → $9
Current: $0.34
Upside: +2,586.57%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $10.70
Upside: +161.68%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $6.97
Upside: +129.56%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.68
Upside: -25.60%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.41
Upside: +3,020.57%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $13.03
Upside: +345.13%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $17.42
Upside: +37.77%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $10.98
Upside: +63.93%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $2.66
Upside: +125.56%
Jun 1, 2022
Maintains: Outperform
Price Target: $46 → $31
Current: $1.13
Upside: +2,643.36%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $5.09
Upside: +450.64%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $251.15
Upside: -30.32%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $3.95
Upside: +254.43%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $36.27
Upside: +197.77%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $32.30
Upside: +141.52%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $9.83
Upside: +917.29%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $10.38
Upside: +1,056.07%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $3.37
Upside: +13,253.12%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.80
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $5.98
Upside: +151.05%
Aug 17, 2018
Maintains: Neutral
Price Target: $240 → $120
Current: $0.74
Upside: +16,116.22%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $5.76
Upside: +229.86%